Original Literature | Model OverView |
---|---|
Publication
Title
LPS/TLR4 signal transduction pathway.
Affiliation
The Campbell Family Institute for Breast Cancer Research, Ontario CancerInstitute, 610 University Avenue, Toronto, Ont., Canada M5G 2M9.
Abstract
The stimulation of Toll-like receptor 4 (TLR4) by lipopolysaccharide (LPS)induces the release of critical proinflammatory cytokines that are necessary toactivate potent immune responses. LPS/TLR4 signaling has been intensivelystudied in the past few years. Here we review molecules involved inTLR4-mediated signaling, including players that are involved in the negativeregulation of this important pathway.
PMID
18304834
|
Entity
NF-kappaB{active}
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m38
10
infinite
0
TRANSPATH | MO000000058 |
--
MAPKs
--
MO000000077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m69
10
infinite
0
TRANSPATH | MO000000077 |
--
IKK-alpha
--
MO000000210
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m181
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
IKK-gamma
--
MO000016599
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1593
10
infinite
0
InterPro | IPR007087 |
TRANSPATH | MO000016599 |
--
TLR4
--
MO000019394
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3961
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019394 |
--
LPS:LBP:CD14
--
MO000021929
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6255
10
infinite
0
TRANSPATH | MO000021929 |
--
TIRAP
--
MO000022528
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6810
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000022528 |
--
TRIF
--
MO000041125
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m18998
10
infinite
0
TRANSPATH | MO000041125 |
--
degradants
--
e10
cso30:c:EntityBiological
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m10
0
infinite
0
--
TLR9:CpGDNA
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
ssRNA
--
e12
cso30:c:Rna
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
TLR7:ssRNA
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
TLR8:ssRNA
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
F protein
--
e16
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
TLR4:F protein
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
Envelope protein
--
e18
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
TLR4:envelope protein
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
TLR4:MD-2
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
TLR4:LPS oligomer
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
TLR4:LPS oligomer:TIRAP
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
TLR4:LPS oligomer:TIRAP:MyD88
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
TLR4:LPS:TIRAP:MyD88:IRAK-4{active}
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
IRAK1
--
e25
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
TLR4:LPS:TIRAP:MyD88:IRAK-4{active}:IRAK1{active}
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
TLR4:LPS:TIRAP:MyD88:IRAK-4{active]
--
e28
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m28
0
infinite
0
--
IRAK1 degradants
--
e29
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
UVE1A
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
TRAF6{active}:Ubc13:UVE1A
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
TAK1{active}
--
e32
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m32
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016574 |
--
MAPKs{active}
--
e34
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m34
10
infinite
0
TRANSPATH | MO000000077 |
--
NF-KappaB:IKappaB
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
NF-KappaB:IKappaB{p}
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
degradants
--
e37
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
proinflammatory cytokines
--
e39
cso30:c:Rna
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m40
0
infinite
0
--
LPS:TLR4:TRAM
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
LPS:TLR4:TRAM:TRIF
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
RIP1
--
e43
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
LPS:TLR4:TRAM:TRIF:RIP1
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
LPS:TLR4:TRAM:TRIF:TRAF3
--
e45
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m46
0
infinite
0
--
csml-variable:Double
m47
0
infinite
0
--
LPS:TLR4:TRAM:TRIF:TRAF3:TANK:IKKi:TBK1
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
IRF3:IRF3
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
TLR2:TLR6
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LTA
--
e6
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
IRF3:IRF3
--
e63
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
Type I interferons
--
e64
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m65
0
infinite
0
--
RP105:MD-1
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
TLR4:MD-2:RP105:MD-1
--
e66
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m67
0
infinite
0
--
ST2L:MyD88
--
e67
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m68
0
infinite
0
--
ST2L:TIRAP
--
e68
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m70
0
infinite
0
--
TRIAD3A
--
e69
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m71
0
infinite
0
--
TLR2:TLR6:LTA
--
e7
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m7
0
infinite
0
--
TRIAD3A:RIP1
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m72
0
infinite
0
--
TRIAD3A:TRIF
--
e71
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m73
0
infinite
0
--
TRIAD3A:TIRAP
--
e72
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m74
0
infinite
0
--
TIRAP{ub}
--
e74
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m76
0
infinite
0
--
caspases
--
e75
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m77
0
infinite
0
--
TRIF:TRAF4
--
e76
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m78
0
infinite
0
--
TRAF1cleaved fragments
--
e77
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m79
0
infinite
0
--
TRAF4:TRAF6
--
e78
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m80
0
infinite
0
--
--
e79
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m81
0
infinite
0
--
TLR2:TLR6:PGN
--
e8
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e80
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m82
0
infinite
0
--
--
e81
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m83
0
infinite
0
--
--
e82
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m84
0
infinite
0
--
--
e83
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m85
0
infinite
0
--
--
e84
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m86
0
infinite
0
--
--
e85
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m87
0
infinite
0
--
--
e86
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m88
0
infinite
0
--
CpGDNA
--
e9
cso30:c:Dna
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m18*m3961*0.1
nodelay
--
0
PMID: 1830483,11854525,11062499 Evidence suggests that several PAMPs can stimulate TLR4. These molecules include lipopolysaccharide (LPS) from Gram-negative bacteria, fusion (F) protein from respiratory syncytial virus (RSV) and the envelope protein from mouse mammary tumor virus (MMTV)
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m6254*m2828*0.1
nodelay
--
0
PMID: 1830483,2427635,2477488 LBP is a soluble shuttle protein which directly binds to LPS and facilitates the association between LPS and CD14
p12
p12
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c36 : 1
m3961*m6438*0.1
nodelay
--
0
PMID: 1830483,1698311 CD14 facilitates the transfer of LPS to the TLR4/MD-2 receptor complex and modulates LPS recognition
p13
p13
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c130 : 1
stoichiometry:c39 : 1
m6255*m20*0.1
nodelay
--
0
PMID: 1830483,1698311 CD14 facilitates the transfer of LPS to the TLR4/MD-2 receptor complex and modulates LPS recognition PMID: 18304834 By interacting with TLR4/MD-2 directly, RP105/MD-1 can inhibit the association between LPS and TLR4/MD-2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m15*0.1
nodelay
--
0
PMID: 1830483 Upon LPS recognition, TLR4 undergoes oligomerization and recruits its downstream adaptors through interactions with the TIR (Toll-interleukin-1 receptor) domains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c137 : 1
stoichiometry:c44 : 1
m21*m6810*0.1
nodelay
--
0
PMID: 1830483,16751103 TIRAP then facilitates the association between MyD88 and the TLR4 cytoplasmic domain to initiate MyD88-dependent downstream signaling PMID:18304834 ST2L can interact with MyD88 and TIRAP and inhibit their function by sequestration, thereby preventing recruitment to TLR4.
p15
p16
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c138 : 1
stoichiometry:c139 : 1
stoichiometry:c47 : 1
m22*m1572*0.1
nodelay
--
0
PMID: 1830483,16751103 TIRAP then facilitates the association between MyD88 and the TLR4 cytoplasmic domain to initiate MyD88-dependent downstream signaling PMID: 1830483,15866876 Another IL-1R homolog, SIGIRR, inhibits TLR4¡Çs interaction with MyD88 through the TIR domain of SIGIRR PMID:18304834 ST2L can interact with MyD88 and TIRAP and inhibit their function by sequestration, thereby preventing recruitment to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m23*m17258*0.1
nodelay
--
0
PMID: 1830483 . Upon LPS stimulation, MyD88 recruits and activates a death domain-containing kinase, IL-1 receptor-associated kinase-4 (IRAK-4)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m24*m25*0.1
nodelay
--
0
PMID: 1830483,15292196 Biochemical evidence also suggests that IRAK-4 is responsible for the subsequent recruitment, activation and degradation of IRAK-1
p19
p19
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c2 : 1
stoichiometry:c57 : 1
m183*m26*0.1
nodelay
--
0
PMID: 1830483 Another adaptor protein TRAF6 (TNF receptor-associated factor 6), is critical for the MyD88-dependent pathway downstream of IRAK4 and IRAK1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m5*m6*0.1
nodelay
--
0
PMID: 18304834 For example, the TLR2/TLR6 heterodimer can be stimulated by several bacterial components, such as lipoteichoic acid (LTA) and peptidoglycan (PGN)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m25*0.1
nodelay
--
0
PMID: 1830483,15292196 Biochemical evidence also suggests that IRAK-4 is responsible for the subsequent recruitment, activation and degradation of IRAK-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m27*m6443*m30*0.1
nodelay
--
0
PMID: 1830483, TRAF6 forms a complex with UBC13 (ubiquitin-conjugating enzyme 13) and UEV1A (ubiquitin-conjugating enzyme E2 variant 1 isoform A), and activates TAK1 (transforming growth factor-¦Â-activated kinase 1)
p22
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m31*m1573*0.1
nodelay
--
0
PMID: 1830483, TRAF6 forms a complex with UBC13 (ubiquitin-conjugating enzyme 13) and UEV1A (ubiquitin-conjugating enzyme E2 variant 1 isoform A), and activates TAK1 (transforming growth factor-¦Â-activated kinase 1)
p23
p23
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
stoichiometry:c70 : 1
m182*m181*m1593*0.1
nodelay
--
0
PMID: 1830483 TAK1 then activates downstream IKK (I¦ÊB kinase) and MAPK (mitogen-activated protein kinase) pathways PMID: 1830483 IKKalpha, IKK¦Â and IKK¦Ã form a complex and phosphorylate I¦ÊB (inhibitor of ¦Ê light chain gene enhancer in B cells) proteins
p24
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m32*m207*0.1
nodelay
--
0
PMID: 1830483 TAK1 then activates downstream IKK (I¦ÊB kinase) and MAPK (mitogen-activated protein kinase) pathways
p24
p25
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m32*m69*0.1
nodelay
--
0
PMID: 1830483 TAK1 then activates downstream IKK (I¦ÊB kinase) and MAPK (mitogen-activated protein kinase) pathways
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m35*m33*0.1
nodelay
--
0
PMID: 18304834 This phosphorylation leads to the degradation of I¦ÊB proteins and the subsequent translocation of the transcription factor NF-¦ÊB, which controls the expression of proinflammatory cytokines, in addition to other immune related genes. PMID: 18304834 TRIF induces the cleavage of TRAF1 by caspases (likely caspase-8) and the cleaved fragment of TRAF1 can inhibit TRIF-induced NF-¦ÊB and IRF3 activation
p27
p27
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m36*0.1
nodelay
--
0
PMID: 1830483 This phosphorylation leads to the degradation of I¦ÊB proteins and the subsequent translocation of the transcription factor NF-¦ÊB, which controls the expression of proinflammatory cytokines, in addition to other immune related genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m38*0.1
nodelay
--
0
PMID: 1830483 This phosphorylation leads to the degradation of I¦ÊB proteins and the subsequent translocation of the transcription factor NF-¦ÊB, which controls the expression of proinflammatory cytokines, in addition to other immune related genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m39*0.1
nodelay
--
0
PMID: 1830483 This phosphorylation leads to the degradation of I¦ÊB proteins and the subsequent translocation of the transcription factor NF-¦ÊB, which controls the expression of proinflammatory cytokines, in addition to other immune related genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m155701*m5*0.1
nodelay
--
0
PMID: 18304834 For example, the TLR2/TLR6 heterodimer can be stimulated by several bacterial components, such as lipoteichoic acid (LTA) and peptidoglycan (PGN)
p30
p30
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m34*m219*0.1
nodelay
--
0
PMID: 1830483 Activation of the downstream MAPK pathways leads to the induction of another transcription factor AP-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m41*0.1
nodelay
--
0
PMID: 1830483 Activation of the downstream MAPK pathways leads to the induction of another transcription factor AP-1,which also has a role in the expression of proinflammatory cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m21*m19005*0.1
nodelay
--
0
PMID: 1830483 TRIF is an important TIR-containing adaptor protein that mediates MyD88-independent signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m42*m18998*0.1
nodelay
--
0
PMID: 1830483 TRIF is an important TIR-containing adaptor protein that mediates MyD88-independent signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m44*m43*0.1
nodelay
--
0
PMID: 18304834 The C-terminal region of TRIF, which contains a Rip homotypic interaction motif (RHIM), mediates the interaction with RIP1 (receptor-interacting protein 1).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m1872*m14*0.1
nodelay
--
0
PMID: 1830483 Experiments suggest that TRIF recruits TRAF3 to activate IRF3, and accordingly the induction of Type I interferons was defective in TRAF3-deficient cells
p36
p36
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m3897*m47*m3902*m46*0.1
nodelay
--
0
PMID: 18304834,16306936,17327220 TRAF3 can associate with TANK (TRAF family member-associated NF-¦ÊB activator), TBK1 (TANK binding kinase 1) and IKKi to mediate downstream signaling
p37
p37
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c176 : 1
stoichiometry:c111 : 1
m48*m977*0.1
nodelay
--
0
PMID: 18304834,12692549,15210742 Experiments suggest that TRIF recruits TRAF3 to activate IRF3, and accordingly the induction of Type I interferons was defective in TRAF3-deficient cells PMID: 18304834 TRIF induces the cleavage of TRAF1 by caspases (likely caspase-8) and the cleaved fragment of TRAF1 can inhibit TRIF-induced NF-¦ÊB and IRF3 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
m49*0.1
nodelay
--
0
PMID: 18304834,12692549,15210742 TBK1 and IKKi are important for the dimerization and translocation of IRF3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m63*0.1
nodelay
--
0
PMID: 18304834,12692549,15210742 TBK1 and IKKi are important for the dimerization and translocation of IRF3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m19828*m9*0.1
nodelay
--
0
PMID: 18304834 Viral DNA is rich in unmethylated CpG motifs, which stimulates TLR9
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m64*0.1
nodelay
--
0
PMID: 18304834,16006187,16932750 IRF3, together with NF-¦ÊB, activates the transcription of target genes, such as Type I interferons
p41
p41
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m45*m69*0.1
nodelay
--
0
PMID: 18304834 TRIF signals the induction of Type I interferons by recruiting TRAF3 and RIP1 to activate transcription factor IRF3, as well as NF-KappaB and AP-1.
p41
p42
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
stoichiometry:c3 : 1
stoichiometry:c123 : 1
m45*m207*0.1
nodelay
--
0
PMID: 18304834 TRIF signals the induction of Type I interferons by recruiting TRAF3 and RIP1 to activate transcription factor IRF3, as well as NF-KappaB and AP-1.
p43
p43
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m1632*m6500*0.1
nodelay
--
0
PMID: 18304834 Originally identified in B cells, RP105 is a homolog of TLR4 and associates with the MD-2 homolog MD-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
stoichiometry:c129 : 1
m66*m20*0.1
nodelay
--
0
PMID: 18304834 By interacting with TLR4/MD-2 directly, RP105/MD-1 can inhibit the association between LPS and TLR4/MD-2
p45
p45
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
stoichiometry:c133 : 1
m22464*m1572*0.1
nodelay
--
0
PMID:18304834 ST2 L can interact with MyD88 and TIRAP and inhibit their function by sequestration, thereby preventing recruitment to TLR4.
p45
p46
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
m22464*m6810*0.1
nodelay
--
0
PMID:18304834 ST2L can interact with MyD88 and TIRAP and inhibit their function by sequestration, thereby preventing recruitment to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c141 : 1
stoichiometry:c142 : 1
m71*m44*0.1
nodelay
--
0
PMID: 18304834,16968706 TRIAD3A can interact with certain TIR domain containing proteins, such as TIRAP, TRIF and RIP1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c1 : 1
stoichiometry:c145 : 1
m71*m18998*0.1
nodelay
--
0
PMID: 18304834,16968706 TRIAD3A can interact with certain TIR domain containing proteins, such as TIRAP, TRIF and RIP1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c146 : 1
stoichiometry:c147 : 1
stoichiometry:c148 : 1
m71*m6810*0.1
nodelay
--
0
PMID: 18304834,16968706 TRIAD3A can interact with certain TIR domain containing proteins, such as TIRAP, TRIF and RIP1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m19940*m12*0.1
nodelay
--
0
PMID: 18304834 While TLR3 interacts with viral double-stranded RNA, TLR7/8 can sense guanosine- or uridine-rich single-stranded RNA from viruses
p50
p50
cso30:i:ME_UnknownDegradation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c150 : 1
stoichiometry:c151 : 1
m3961*m71*0.1
nodelay
--
0
PMID: 18304834,15866876,15107846 Overexpression of TRIAD3A can promote the degradation of TLR4, TIRAP, TRIF and RIP1 [
p50
p51
cso30:i:ME_UnknownDegradation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c153 : 1
stoichiometry:c154 : 1
m71*m6810*0.1
nodelay
--
0
PMID: 18304834,15866876,15107846 Overexpression of TRIAD3A can promote the degradation of TLR4, TIRAP, TRIF and RIP1 [
p50
p52
cso30:i:ME_UnknownDegradation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
stoichiometry:c157 : 1
m71*m18998*0.1
nodelay
--
0
PMID: 18304834,15866876,15107846 Overexpression of TRIAD3A can promote the degradation of TLR4, TIRAP, TRIF and RIP1 [
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c159 : 1
stoichiometry:c160 : 1
m71*m44*0.1
nodelay
--
0
PMID: 18304834,15866876,15107846 Overexpression of TRIAD3A can promote the degradation of TLR4, TIRAP, TRIF and RIP1 [
p54
p54
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c161 : 1
stoichiometry:c163 : 1
stoichiometry:c181 : 1
stoichiometry:c185 : 1
stoichiometry:c162 : 1
m75*0.1
nodelay
--
0
PMID: 18304834,15107846 TRIAD3A overexpression can downregulate NF-¦ÊB activation, and knockingdown TRIAD3A expression upregulates NF-¦ÊB activation upon LPS stimulation PMID: 18304834,16415872 TRAF4 overexpression can inhibit NF-¦ÊB activation possibly through the interaction with TRIF and TRAF6
p55
p55
cso30:i:ME_Ubiquitination
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c165 : 1
stoichiometry:c166 : 1
m1906*m6810*0.1
nodelay
--
0
PMID: 18304834 SOCS-1 can induce the ubiquitination of TIRAP which leads to its subsequent degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c167 : 1
stoichiometry:c168 : 1
m76*0.1
nodelay
--
0
PMID: 18304834 SOCS-1 can induce the ubiquitination of TIRAP which leads to its subsequent degradation
p57
p57
cso30:i:ME_Dissociation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c171 : 1
stoichiometry:c169 : 1
stoichiometry:c170 : 1
m26*0.1
nodelay
--
0
PMID: 1830483,15292196 Biochemical evidence also suggests that IRAK-4 is responsible for the subsequent recruitment, activation and degradation of IRAK-1 PMID: 18304834 Studies have suggested that IRAK-M inhibits MyD88-mediated signaling by preventing the dissociation of IRAKs from MyD88.
p58
p58
cso30:i:ME_Cleavage
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c172 : 1
stoichiometry:c173 : 1
stoichiometry:c174 : 1
stoichiometry:c175 : 1
m18998*m77*m1871*0.1
nodelay
--
0
PMID: 18304834 TRIF induces the cleavage of TRAF1 by caspases (likely caspase-8) and the cleaved fragment of TRAF1 can inhibit TRIF-induced NF-¦ÊB and IRF3 activation
p59
p59
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c179 : 1
stoichiometry:c180 : 1
m1873*m18998*0.1
nodelay
--
0
PMID: 18304834,16415872 TRAF4 overexpression can inhibit NF-¦ÊB activation possibly through the interaction with TRIF and TRAF6
p5
p6
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c18 : 1
stoichiometry:c17 : 1
m3965*m119368*0.1
nodelay
--
0
PMID: 1830483 While TLR3 interacts with viral double-stranded RNA, TLR7/8 can sense guanosine- or uridine-rich single-stranded RNA from viruses
p59
p60
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c182 : 1
stoichiometry:c183 : 1
stoichiometry:c184 : 1
m1873*m183*0.1
nodelay
--
0
PMID: 18304834,16415872 TRAF4 overexpression can inhibit NF-¦ÊB activation possibly through the interaction with TRIF and TRAF6
p61
p61
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c187 : 1
stoichiometry:c188 : 1
m3964*m3987*0.1
nodelay
--
0
PMID: 18304834 For example, the TLR2/TLR6 heterodimer can be stimulated by several bacterial components, such as lipoteichoic acid (LTA) and peptidoglycan (PGN)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m19823*m12*0.1
nodelay
--
0
PMID: 18304834 While TLR3 interacts with viral double-stranded RNA, TLR7/8 can sense guanosine- or uridine-rich single-stranded RNA from viruses
p8
p8
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m155666*m3985*0.1
nodelay
--
0
PMID: 1830483,2427635,2477488 LBP is a soluble shuttle protein which directly binds to LPS and facilitates the association between LPS and CD14
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c35 : 1
stoichiometry:c27 : 1
m16*m3961*0.1
nodelay
--
0
PMID: 1830483,11854525,11062499 Evidence suggests that several PAMPs can stimulate TLR4. These molecules include lipopolysaccharide (LPS) from Gram-negative bacteria, fusion (F) protein from respiratory syncytial virus (RSV) and the envelope protein from mouse mammary tumor virus (MMTV)
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--